HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Common EGFR mutations conferring sensitivity to gefitinib in lung adenocarcinoma are not prevalent in human malignant mesothelioma.

AuthorsJoseph F Cortese, Ashok L Gowda, Anil Wali, James F Eliason, Harvey I Pass, Richard B Everson
JournalInternational journal of cancer (Int J Cancer) Vol. 118 Issue 2 Pg. 521-2 (Jan 15 2006) ISSN: 0020-7136 [Print] United States
PMID16052537 (Publication Type: Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Quinazolines
  • ErbB Receptors
  • Protein-Tyrosine Kinases
  • Gefitinib
Topics
  • Adenocarcinoma (drug therapy, genetics)
  • Antineoplastic Agents (pharmacology)
  • DNA Mutational Analysis
  • Drug Resistance, Neoplasm
  • ErbB Receptors (genetics, physiology)
  • Gefitinib
  • Genetic Testing
  • Humans
  • Lung Neoplasms (drug therapy, genetics)
  • Mesothelioma (drug therapy, genetics)
  • Point Mutation
  • Polymerase Chain Reaction
  • Protein-Tyrosine Kinases (genetics)
  • Quinazolines (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: